DNA aptamer-empowered self-assembly full-API nanodrug for enhanced photodynamic and chemotherapy synergistic cancer therapy
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced biosensing and bioanalysis techniques · Nanoplatforms for cancer theranostics · Gold and Silver Nanoparticles Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (39)
Show source-provided references
1. Nanotechnology-based strategies against SARS-CoV-2 variants10.1038/s41565-022-01174-5 ↗
2. Smart cancer nanomedicine10.1038/s41565-019-0567-y ↗
3. Nanotechnology-facilitated vaccine development during the coronavirus disease 2019 (COVID-19) pandemic10.1002/EXP.20210082 ↗
4. Engineering precision nanoparticles for drug delivery10.1038/s41573-020-0090-8 ↗
5. Obstacles and opportunities in a forward vision for cancer nanomedicine10.1038/s41563-021-01047-7 ↗
6. Cancer nanomedicine: progress, challenges and opportunities10.1038/nrc.2016.108 ↗
7. Self-assembling a natural small molecular inhibitor that shows aggregation-induced emission and potentiates antitumor efficacy10.1039/D0NH00469C ↗
8. Quantitative self-assembly of photoactivatable small molecular prodrug cocktails for safe and potent cancer chemo-photodynamic therapy10.1016/j.nantod.2020.101030 ↗
9. Quantitative self-assembly of pure drug cocktails as injectable nanomedicines for synergistic drug delivery and cancer therapy10.7150/thno.55250 ↗
10. Carrier-free nanomedicines for cancer treatment10.1016/j.pmatsci.2021.100919 ↗
11. Clinical application of polymeric micelles for the treatment of cancer10.1039/C6QM00289G ↗
12. A First-in-human phase 1 study of epirubicin-conjugated polymer micelles (K-912/NC-6300) in patients with advanced or recurrent solid tumors10.1007/s10637-016-0422-z ↗
13. Phase Ib/II Trial of NC-6004 (Nanoparticle Cisplatin) plus gemcitabine in patients with advanced solid tumors10.1158/1078-0432.CCR-17-1114 ↗
14. Drug nanocrystals for cancer therapy10.1002/wnan.1499 ↗
15. XMT-1001, a novel polymeric camptothecin pro-drug in clinical development for patients with advanced cancer10.1016/j.addr.2009.01.007 ↗
16. Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy10.1016/j.biomaterials.2020.120557 ↗
17. Continuous spatiotemporal therapy of a full-API nanodrug via multi-step tandem endogenous biosynthesis
18. The evolution of commercial drug delivery technologies10.1038/s41551-021-00698-w ↗
19. Clinical development and potential of photothermal and photodynamic therapies for cancer10.1038/s41571-020-0410-2 ↗
20. Carrier-free nanodrugs with efficient drug delivery and release for cancer therapy: from intrinsic physicochemical properties to external modification
21. Carrier-free delivery of precise drug–chemogene conjugates for synergistic treatment of drug-resistant cancer10.1002/anie.202006895 ↗
22. Elaborately engineering a self-indicating dual-drug nanoassembly for site-specific photothermal-potentiated thrombus penetration and thrombolysis10.1002/advs.202104264 ↗
23. Self-assembly of copper–DNAzyme nanohybrids for dual-catalytic tumor therapy10.1002/anie.202101744 ↗
24. Aptamers as targeted therapeutics: current potential and challenges10.1038/nrd.2016.199 ↗
25. Aptamer-LYTACs for targeted degradation of extracellular and membrane proteins
26. Aptamer-targeted photodynamic platforms for tumor therapy10.1021/acsami.1c06818 ↗
27. Aptamer-based targeted therapy10.1016/j.addr.2018.08.005 ↗
28. Aptamer-based targeted delivery of functional nucleic acids10.1021/jacs.3c00841 ↗
29. Molecular engineering of aptamer to solubilize hydrophobic near-infrared photosensitizer for enhanced cancer photodynamic therapy10.31635/ccschem.023.202303161 ↗
30. Molecular self-assembly of bioorthogonal aptamer-prodrug conjugate micelles for hydrogen peroxide and ph-independent cancer chemodynamic therapy10.1021/jacs.9b10755 ↗
31. Optimization in solvent selection for chlorin E6 in photodynamic therapy10.1007/s10895-012-1146-x ↗
32. L. Zhao, R. Zheng, H. Chen, L. Liu, X. Zhao, H. Liu, X. Qiu, X. Yu, H. Cheng, S. Li, 2020, , Self-Deliv. Nanomed. O2 ‑ Econ. Photodyn. Tumor Ther. 20 (3)2062–2071.10.1021/acs.nanolett.0c00047 ↗
33. Self-delivery photo-immune stimulators for photodynamic sensitized tumor immunotherapy10.1021/acsnano.0c06765 ↗
34. Journal of colloid and interface science self-delivery nanomedicine for vascular disruption-supplemented chemo-photodynamic tumor therapy10.1016/j.jcis.2021.12.128 ↗
35. Chlorin e6: a promising photosensitizer in photo-based cancer nanomedicine10.1021/acsabm.2c00891 ↗
36. Irinotecan induces senescence and apoptosis in colonic cells in vitro10.1016/j.toxlet.2012.08.004 ↗
37. Synergistic effects of simvastatin and irinotecan against colon cancer cells with or without irinotecan resistance10.1155/2016/7891374 ↗
38. Aptamer-functionalized nanoparticles in targeted delivery and cancer therapy10.3390/ijms21239123 ↗
39. Regulating the anticancer efficacy of Sgc8–combretastatin A4 conjugates: a case of recognizing the significance of linker chemistry for the design of aptamer-based targeted drug delivery strategies10.1021/jacs.1c03013 ↗